125 related articles for article (PubMed ID: 9730223)
1. A rational strategy for enhancing the affinity of vancomycin towards depsipeptide ligands.
Axelsen PH; Li D
Bioorg Med Chem; 1998 Jul; 6(7):877-81. PubMed ID: 9730223
[TBL] [Abstract][Full Text] [Related]
2. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.
Lessard IA; Healy VL; Park IS; Walsh CT
Biochemistry; 1999 Oct; 38(42):14006-22. PubMed ID: 10529248
[TBL] [Abstract][Full Text] [Related]
3. Deconstructing vancomycin.
Walsh C
Science; 1999 Apr; 284(5413):442-3. PubMed ID: 10232990
[No Abstract] [Full Text] [Related]
4. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
Ge M; Chen Z; Onishi HR; Kohler J; Silver LL; Kerns R; Fukuzawa S; Thompson C; Kahne D
Science; 1999 Apr; 284(5413):507-11. PubMed ID: 10205063
[TBL] [Abstract][Full Text] [Related]
5. The structural biology of molecular recognition by vancomycin.
Loll PJ; Axelsen PH
Annu Rev Biophys Biomol Struct; 2000; 29():265-89. PubMed ID: 10940250
[TBL] [Abstract][Full Text] [Related]
6. The role of configurational entropy in biochemical cooperativity.
Jusuf S; Loll PJ; Axelsen PH
J Am Chem Soc; 2002 Apr; 124(14):3490-1. PubMed ID: 11929222
[TBL] [Abstract][Full Text] [Related]
7. 19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces that mimic VanA and VanB resistance.
Entress RM; Dancer RJ; O'Brien DP; Try AC; Cooper MA; Williams DH
Chem Biol; 1998 Jun; 5(6):329-37. PubMed ID: 9653551
[TBL] [Abstract][Full Text] [Related]
8. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.
Cooper MA; Fiorini MT; Abell C; Williams DH
Bioorg Med Chem; 2000 Nov; 8(11):2609-16. PubMed ID: 11092546
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding.
Loll PJ; Kaplan J; Selinsky BS; Axelsen PH
J Med Chem; 1999 Nov; 42(22):4714-9. PubMed ID: 10579833
[TBL] [Abstract][Full Text] [Related]
10. A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin.
Rao J; Lahiri J; Isaacs L; Weis RM; Whitesides GM
Science; 1998 May; 280(5364):708-11. PubMed ID: 9563940
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
Ślusarz R; Szulc M; Madaj J
Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
[TBL] [Abstract][Full Text] [Related]
13. MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine.
Good VM; Gwynn MN; Knowles DJ
J Antibiot (Tokyo); 1990 May; 43(5):550-5. PubMed ID: 2113517
[TBL] [Abstract][Full Text] [Related]
14. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
Lee JG; Sagui C; Roland C
J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
[TBL] [Abstract][Full Text] [Related]
15. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria.
Hassan MM; Ranzoni A; Phetsang W; Blaskovich MA; Cooper MA
Bioconjug Chem; 2017 Feb; 28(2):353-361. PubMed ID: 27959504
[TBL] [Abstract][Full Text] [Related]
16. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation.
Park IS; Walsh CT
J Biol Chem; 1997 Apr; 272(14):9210-4. PubMed ID: 9083053
[TBL] [Abstract][Full Text] [Related]
17. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.
McComas CC; Crowley BM; Boger DL
J Am Chem Soc; 2003 Aug; 125(31):9314-5. PubMed ID: 12889959
[TBL] [Abstract][Full Text] [Related]
18. Synchronized conformational fluctuations and binding site desolvation during molecular recognition.
Jusuf S; Axelsen PH
Biochemistry; 2004 Dec; 43(49):15446-52. PubMed ID: 15581356
[TBL] [Abstract][Full Text] [Related]
19. Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci.
Rodriguez MJ; Snyder NJ; Zweifel MJ; Wilkie SC; Stack DR; Cooper RD; Nicas TI; Mullen DL; Butler TF; Thompson RC
J Antibiot (Tokyo); 1998 Jun; 51(6):560-9. PubMed ID: 9711219
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of oritavancin and related glycopeptide antibiotics.
Allen NE; Nicas TI
FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]